Puma Biotechnology, Inc. (PBYI)
9.55
+0.14
(+1.49%)
USD |
NASDAQ |
Sep 04, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Shareholders Equity (Quarterly) : 138.54M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 138.54M |
| March 31, 2026 | 128.42M |
| December 31, 2025 | 130.34M |
| September 30, 2025 | 115.27M |
| June 30, 2025 | 104.72M |
| March 31, 2025 | 97.11M |
| December 31, 2024 | 92.12M |
| September 30, 2024 | 71.09M |
| June 30, 2024 | 48.51M |
| March 31, 2024 | 50.98M |
| December 31, 2023 | 53.44M |
| September 30, 2023 | 38.74M |
| June 30, 2023 | 30.40M |
| March 31, 2023 | 25.85M |
| December 31, 2022 | 21.61M |
| September 30, 2022 | 22.16M |
| June 30, 2022 | 19.74M |
| March 31, 2022 | 7.145M |
| December 31, 2021 | -2.446M |
| September 30, 2021 | -10.92M |
| June 30, 2021 | 29.47M |
| March 31, 2021 | 16.44M |
| December 31, 2020 | -5.951M |
| September 30, 2020 | -0.453M |
| June 30, 2020 | 23.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.377M |
| December 31, 2019 | 17.46M |
| September 30, 2019 | 17.18M |
| June 30, 2019 | 21.77M |
| March 31, 2019 | 43.47M |
| December 31, 2018 | 34.31M |
| September 30, 2018 | 45.91M |
| June 30, 2018 | 38.30M |
| March 31, 2018 | 57.46M |
| December 31, 2017 | 53.30M |
| September 30, 2017 | 79.17M |
| June 30, 2017 | 120.11M |
| March 31, 2017 | 167.39M |
| December 31, 2016 | 209.82M |
| September 30, 2016 | 91.15M |
| June 30, 2016 | 127.08M |
| March 31, 2016 | 164.94M |
| December 31, 2015 | 206.01M |
| September 30, 2015 | 244.84M |
| June 30, 2015 | 274.78M |
| March 31, 2015 | 304.34M |
| December 31, 2014 | 117.05M |
| September 30, 2014 | 141.60M |
| June 30, 2014 | 167.04M |
| March 31, 2014 | 198.79M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 220.58M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.74M |
| Total Liabilities (Quarterly) | 54.19M |
| Debt to Equity Ratio | 0.0348 |
| Current Ratio | 2.912 |
| Net Debt Paydown Yield | 2.75% |